CAPR - Capricor Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CAPR is currently covered by 1 analysts with an average price target of $26.06. This is a potential upside of $20.07 (335.06%) from yesterday's end of day stock price of $5.99.

Capricor Therapeutics's activity chart (see below) currently has 11 price targets and 14 ratings on display. The stock rating distribution of CAPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.81% with an average time for these price targets to be met of 436.5 days.

Highest price target for CAPR is $40, Lowest price target is $40, average price target is $26.06.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 14-May-2024. First documented stock forecast 15-Sep-2017.

Best performing analysts who are covering CAPR - Capricor Therapeutics:

Jason Mccarthy Joseph Pantginis

Currently out of the existing stock ratings of CAPR, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

40

$34.01 (567.78%)

12 days ago

1/7 (14.29%)

$34.8 (669.23%)

787

Buy

12

$6.01 (100.33%)

10

4 years 13 days ago

1/3 (33.33%)

$5.34 (80.18%)

86

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CAPR (Capricor Therapeutics) average time for price targets to be met?

On average it took 436.5 days on average for the stock forecasts to be realized with a an average price target met ratio 23.81

Which analyst has the current highest performing score on CAPR (Capricor Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the current lower performing score on CAPR (Capricor Therapeutics) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on CAPR (Capricor Therapeutics)?

Jason Mccarthy works at MAXIM GROUP and has 2 price targets and 2 ratings on CAPR

Which analyst is the currently most bullish on CAPR (Capricor Therapeutics)?

Joseph Pantginis with highest potential upside - $34.01

Which analyst is the currently most reserved on CAPR (Capricor Therapeutics)?

Jason Mccarthy with lowest potential downside - $6.01

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?